These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22340298)

  • 1. Drug-eluting versus bare-metal stents in saphenous vein graft lesions.
    Brilakis ES; Banerjee S; Shunk KA; Bhatt DL
    Lancet; 2012 Feb; 379(9816):615; author reply 615-6. PubMed ID: 22340298
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial.
    Mehilli J; Pache J; Abdel-Wahab M; Schulz S; Byrne RA; Tiroch K; Hausleiter J; Seyfarth M; Ott I; Ibrahim T; Fusaro M; Laugwitz KL; Massberg S; Neumann FJ; Richardt G; Schömig A; Kastrati A;
    Lancet; 2011 Sep; 378(9796):1071-8. PubMed ID: 21872918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting versus bare-metal stents for saphenous vein graft lesions.
    Conte SM; Florisson DS; De Bono JA; Vale PR
    Intern Med J; 2019 Dec; 49(12):1534-1537. PubMed ID: 31808253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stents and failing vein grafts: are we any wiser after ISAR?
    Taggart DP; Banning AP
    Lancet; 2011 Sep; 378(9796):1054-5. PubMed ID: 21872921
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions.
    Rozenman Y
    JACC Cardiovasc Interv; 2011 May; 4(5):590-1; author reply 591-3. PubMed ID: 21596337
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparing Drug-Eluting Stents to Bare-Metal Stents for Saphenous Vein Graft Lesion PCI.
    Banerjee S; Brilakis ES
    J Invasive Cardiol; 2016 Dec; 28(12):E170-E171. PubMed ID: 27922807
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of long-term outcomes of drug-eluting stents and bare metal stents for saphenous vein graft stenosis.
    Chakravarty T; Morrissey RP; Wertman B; Naghi J; Chou S; Goykhman P; Doctor N; Mirocha J; Forrester JS; Makkar R
    Catheter Cardiovasc Interv; 2012 May; 79(6):903-9. PubMed ID: 21805570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
    Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
    JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term follow-up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesions.
    Ybarra LF; Ribeiro HB; Pozetti AH; Campos CA; Esper RB; Lemos PA; Lopes AC; Kalil-Filho R; Ellis SG; Ribeiro EE
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E856-63. PubMed ID: 23239630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions: Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial.
    Sosa A; Chao H; Guerra A; Han H; Christopoulos G; Christakopoulos GE; Tarar MN; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Banerjee S; Brilakis ES
    Int J Cardiol; 2015; 186():261-3. PubMed ID: 25828130
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: a comprehensive meta-analysis of randomized trials and observational studies comprising 7,994 patients.
    Hakeem A; Helmy T; Munsif S; Bhatti S; Mazraeshahi R; Cilingiroglu M; Effat M; Leesar M; Arif I
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):343-55. PubMed ID: 21328679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up results after interventional treatment of infarct-related saphenous vein graft occlusion.
    Hoffmann R; Nitendo G; Deserno V; Adamu U; Almalla M; Blindt R; Vogt F
    Coron Artery Dis; 2010 Mar; 21(2):61-4. PubMed ID: 20124993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saphenous vein graft interventions: drug-eluting stents are better and safe but not good enough.
    Brilakis ES; Banerjee S
    Catheter Cardiovasc Interv; 2012 May; 79(6):910-1. PubMed ID: 22511377
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of drug-eluting stents versus bare metal stents in saphenous vein graft PCI outcomes: a meta-analysis.
    Mamas MA; Foley J; Nair S; Wiper A; Clarke B; El-Omar M; Fraser DG; Khattar R; Neyses L; Fath-Ordoubadi F
    J Interv Cardiol; 2011 Apr; 24(2):172-80. PubMed ID: 21281356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
    Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should bare metal or drug-eluting stents be used during PCI of saphenous vein graft lesions: waiting for Godot?
    Brilakis ES; Berger PB
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):815-8. PubMed ID: 19006238
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term outcomes with first- vs. second-generation drug-eluting stents in saphenous vein graft lesions.
    Pokala NR; Menon RV; Patel SM; Christopoulos G; Christakopoulos GE; Kotsia AP; Rangan BV; Roesle M; Abdullah S; Grodin J; Kumbhani DJ; Hastings J; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):34-40. PubMed ID: 26033073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting or bare metal stents for the treatment of saphenous vein graft disease: a Bayesian meta-analysis.
    Paradis JM; Bélisle P; Joseph L; Bertrand OF; DeLarochellière R; Déry JP; Larose E; Rodés-Cabau J; Rinfret S
    Circ Cardiovasc Interv; 2010 Dec; 3(6):565-76. PubMed ID: 21098743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
    Hougaard M; Thayssen P; Kaltoft A; Tilsted HH; Maeng M; Lassen JF; Thuesen L; Okkels Jensen L
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1035-42. PubMed ID: 24311384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (EOS) study.
    Jim MH; Ho HH; Ko RL; Siu CW; Yiu KH; Lau CP; Chow WH
    J Interv Cardiol; 2010 Feb; 23(1):40-5. PubMed ID: 20465719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.